How the common cold may help protect against Covid-19
New research suggests ‘memory bank’ of T-cells triggered by colds boosts Covid defences

A free daily digest of the biggest news stories of the day - and the best features from our website
Thank you for signing up to TheWeek. You will receive a verification email shortly.
There was a problem. Please refresh the page and try again.
People who have fought off common colds may have a lower risk of catching Covid-19, according to a newly published study.
The research findings, outlined in a paper in Nature Communications journal, help to “explain why some people never get infected” with Covid, and why older people are “more susceptible” than children, who tend to pick up colds more frequently, said The Telegraph.
In the small-scale study, scientists from Imperial College London (ICL) tested blood taken from 52 people in September 2020 – before Covid vaccines were rolled out – who were living with others who had just tested positive for the coronavirus. A total of 26 went on to get Covid during the 28-day study period.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
In a bid to determine why the other half of the group escaped infection, the researchers looked at “a crucial part of the body’s immune system – T-cells”, said the BBC.
Some of these T-cells “kill any cells infected by a specific threat”, such as a cold virus, the broadcaster explained. And following a cold infection, some “remain in the body as a memory bank, ready to mount a defence against future attacks” by the virus.
The researchers found that the 26 test subjects who did not contract Covid had “significantly higher levels” of “pre-existing T-cells induced by previous common cold coronavirus infections that also cross-recognise proteins” of Sars-CoV-2, the virus that causes Covid-19, according to the ICL website.
‘Blueprint’ for future vaccines
The findings suggest that these protective T-cells may be present in “a good proportion of the population”, study co-author Professor Ajit Lalvani told The Telegraph.
“It explains the good outcomes or resistance to infection for some people,” added Lalvani, director of the NIHR Respiratory Infections Health Protection Research Unit at Imperial.
The researchers believe that the “important discovery” may provide a “blueprint” for the production of a new universal vaccine that “could prevent infection from current and future Sars-CoV-2 variants, including Omicron”, said the ICL website.
Dr Rhia Kundu, first author of the study, stressed that “no one should rely on this alone”, adding: “The best way to protect yourself against Covid-19 is to be fully vaccinated, including getting your booster dose.”
The team and other scientists pointed out that not all colds are coronaviruses. Dr Simon Clarke, of the University of Reading, who was not involved in the study, said: “It could be a grave mistake to think that anyone who has recently had a cold is protected against Covid-19, as coronaviruses only account for 10%-15% of colds.”
Experts said that “other variables – such as ventilation and how infectious their household contact was – would have an impact” on whether people caught Covid, too, the BBC reported.
All the same, said study co-author Lalvani, “learning from what the body does right could help inform the design of new vaccines”.
Current vaccines target spike proteins that sit on the outside of the Covid virus, but those spike proteins can change with new variants.
“In contrast, the internal proteins targeted by the protective T-cells we identified mutate much less,” Lalvani explained. So new vaccines that include these internal proteins would “induce broadly protective T-cell responses that should protect against current and future Sars-CoV-2 variants.”
Continue reading for free
We hope you're enjoying The Week's refreshingly open-minded journalism.
Subscribed to The Week? Register your account with the same email as your subscription.
Sign up to our 10 Things You Need to Know Today newsletter
A free daily digest of the biggest news stories of the day - and the best features from our website
-
'The United States needs to up its game'
Instant opinion Opinion, comment and editorials of the day
By Harold Maass Published
-
'Accepting defeat is Rishi Sunak's only hope of victory'
Instant Opinion Opinion, comment and editorials of the day
By The Week Staff Published
-
Royal family website attacked by Russian hackers
Speed Read Pro-Kremlin group claim responsibility just two weeks after King Charles condemns invasion of Ukraine
By The Week Staff Published
-
How do we calculate mass deaths?
The Explainer Recent revisions to 9/11, Libyan flood and Covid-19 death tolls raise questions over estimates
By Harriet Marsden, The Week UK Published
-
You can now get a new Covid booster shot. Should you?
Unless you are old or otherwise at high risk, it isn't a 'slam dunk'
By Peter Weber Published
-
Is it time to mask up again?
Today's Big Question A rise in Covid-19 cases brings back the possibility of mask mandates
By Joel Mathis Published
-
The NHS plan for virtual wards to beat winter crisis
feature Patients with respiratory infections to be given wearable devices that allow doctors to monitor them at home
By The Week Staff Published
-
Why is a bed-bug epidemic sweeping across the UK?
feature Cost-of-living crisis and post-Covid travel blamed for 65% year-on-year increase
By The Week Staff Published
-
Understanding the new Covid-19 variant, Eris
Speed Read The formally named EG.5 is making the rounds, but we don't have to worry just yet
By Devika Rao Published
-
The new Covid variant Eris behind a rise in cases this summer
feature Concerns over ’flying blind’ as routine testing is no longer freely available and less data is being collected
By Felicity Capon Published
-
The new push to solve long Covid
Speed Read Patients say researchers have been too slow to address the condition
By Joel Mathis Published